Determining the appropriateness of selected surgical and medical management options in recurrent stroke prevention: A guideline for primary care physicians from the National Stroke Association work group on recurrent stroke prevention

Journal of Stroke and Cerebrovascular Diseases

Volumn 13, Issue 5, 2004, Pages 196-207

  Hanley, Daniel ^a,l   Gorelick, Philip B ^b   Elliott, William J ^b   Broder, Michael S ^c   Saver, Jeffrey L ^d   Kidwell, Chelsea S ^d   Fagan, Susan C ^e   Wilson, Alisa ^c   Lennihan, Laura ^f   Schwer, William A ^b   Rubenstein, Laurence Z ^g   Crowell, Robert M ^h   Haines, Stephen J ⁱ   Lopez, Carolyn C ^b,j   Zorowitz, Richard ^k   Dubois, Robert W ^c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b RUSH MEDICAL COLLEGE   (United States)

^c Cerner Health Insights   (United States)

^d UCLA MEDICAL CENTER   (United States)

^e MEDICAL COLLEGE OF GEORGIA   (United States)

^f NEUROLOGICAL INSTITUTE   (United States)

^g VETERANS AFFAIRS MEDICAL CENTER   (United States)

^h UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

ⁱ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^j AMERICAN ACADEMY OF FAMILY PHYSICIANS   (United States)

^k UNIVERSITY OF PENNSYLVANIA   (United States)

^l JOHNS HOPKINS UNIVERSITY   (United States)

more..

Author keywords

appropriateness; prevention; RAND technique; Recurrent stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DIURETIC AGENT; TICLOPIDINE; WARFARIN;

ANGIOPLASTY; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD PRESSURE REGULATION; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; COGNITIVE DEFECT; HEART ATRIUM FIBRILLATION; HEART RHYTHM; HUMAN; HYPERTENSION; MEDICAL DECISION MAKING; MICROSURGERY; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECURRENT DISEASE; STROKE; SURGICAL RISK; TREATMENT INDICATION;

EID: 7044269699     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jstrokecerebrovasdis.2004.05.002     Document Type: Article

References (49)

1. Bonita R. Stroke prevention A global perspective. 2001;Oxford University Press, New York
2. Hickenbottom S., Fendrick A., Kutcher J., et al. A national study of the quantity and cost of informal caregiving for the elderly with stroke. Neurology. 58:2002;1112-1120
3. Gorelick P., Sacco R., Smith D., et al. Prevention of a first stroke A review of guidelines and a multidisciplinary consensus statement from the National Stroke Association. JAMA. 281:1999;1112-1120
4. Goldstein L., Adams R., Becker K., et al. Primary prevention of ischemic stroke A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation. 103:2001;163-182
5. Albers G., Amarenco P., Easton J., et al. Antithrombotic and thrombolytic therapy for ischemic stroke. Chest. 119:(suppl):2001;300S-320S
6. European Committee SIE. European Stroke Initiative recommendations for stroke management. Cerebrovasc Dis. 10:2000;335-351
7. Strauss S., Majumdar S., McAlister F. New evidence for stroke prevention Scientific review. JAMA. 288:2002;1388-1395
8. Pearson T., Blair S., Daniels S., et al. American Heart Association Science Advisory and Coordinating Committee. AHA guidelines for primary prevention of cardiovascular disease and stroke, 2002 update Consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular disease. Circulation. 106:2002;388-391
9. Antithrombotic Collaboration. Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ. 324:2002;71-86
10. Holloway R., Benesch C., Rush S. Stroke prevention Narrowing the evidence-practice gap. Neurology. 54:2000;1899-1906
11. Hart R., Bailey R. An assessment of guidelines for prevention of ischemic stroke. Neurology. 59:2002;977-982
12. Helgason C., Watkins F., Jobe T. Measurable differences between sequential and parallel diagnostic decision processes for determining stroke subtype A representation of interacting pathologies. Thromb Haemost. 88:2002;210-212
13. Park R., Fink A., Brook R., et al. Physician ratings of appropriate indications for three procedures Theoretical indications vs indications used in practice. Am J Public Health. 79:1989;445-447
14. Fitch K., Bernstein S., Aguilar M., et al. The RAND/UCLA appropriateness method user's manual. 2001;The RAND Corporation, Santa Barbara
15. Gage B.F., Waterman A.D., Shannon W., et al. Validation of clinical classification schemes for predicting stroke Results from the National Registry of Atrial Fibrillation. JAMA. 285:2001;2864-2870
16. Winslow C., Solomon D., Chassin M., et al. The appropriateness of carotid endarterectomy. N Engl J Med. 318:1988;721-727
17. European Group CSTC. MRC European Carotid Surgery Trial Interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis. Lancet. 337:1991;1235-1243
18. North Collaborators ASCET. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 325:1991;445-453
19. European Group CSTsC. Randomised trial of endarterectomy for recently symptomatic carotid stenosis Final results of the MRC European Carotid Surgery Trial (ECST). Lancet. 351:1998;1379-1387
20. Barnett H., Taylor D., Eliasziw M., et al. Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. N Engl J Med. 339:1998;1415-1425
21. Rothwell P., Eliasziw M., Gutnikov S., et al. Analysis of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 361:2003;107-116
22. Gray W.A. A cardiologist in the carotids. J Am Coll Cardiol. 43:2004;1602-1605
23. European Group AFTES. Secondary prevention in nonrheumatic atrial fibrillation after transient ischemic attack or minor stroke. Lancet. 342:1993;1255-1262
24. Hart R., Halperin J. Atrial fibrillation and thromboembolism A decade of progress in stroke prevention. Ann Intern Med. 131:1999;688-695
25. Stroke Study PiAFI. Patients with nonvalvular atrial fibrillation at low risk of stroke during treatment with aspirin. JAMA. 279:1998;1273-1277
26. Mohr J., Thompson J., Lazar R., et al. A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med. 345:2001;1444-1451
27. Diener H., Cunha L., Forbes C., et al. European Stroke Prevention Study 2 Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 143:1996;1-13
28. Gorelick P. New horizons for stroke prevention PROGESS and HOPE. Lancet Neurol. 1:2002;149-156
29. PROGRESS Group C. Randomized trial of a perindopril-based blood-pressure lowering regimen among 6105 individuals with previous stroke or transient ischemic attack. Lancet. 358:2001;1033-1041
30. Chobanian A., Bakris G., Black H., et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure The JNC 7 Report. JAMA. 289:2003;2560-2671
31. The Group ALLHAT. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 288:2002;2981-2997
32. Dahlof B., Devereux R., Kjeldsen S., et al. Cardiovascular morbidity and mortality in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE) A randomised trial against atenolol. Lancet. 359:2002;995-1003
33. Ruland S., Raman R., Chaturvedi S., et al. AAASPS Investigators. Awareness, treatment, and control of vascular risk factors in African Americans with stroke. Neurology. 60:2003;54-68
34. Kernan W., Viscoli C., Brass L., et al. Blood pressure exceeding national guidelines among women after stroke. Stroke. 31:2003;415-419
35. Qureshi A., Suri M., Guterman L., et al. Ineffective secondary prevention in survivors of cardiovascular events in the US population Report from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 161:2001;415-419
36. Nieto F., Alonso J., Chambless L., et al. Population awareness and control of hypertension and hypercholestolemia The Atherosclerosis Risk in Communities Study. Arch Intern Med. 155:1995;677-684
37. Tipton M., Fleming M. Stroke prevention in managed care A five dimensional health improvement model. 2002;Parthenon Publishing, New York
38. Gorelick P. An integrated approach to stroke prevention. 3rd ed.:2002;Science Press, London
39. Miller N., Hill M., Kottke T., et al. The multilevel compliance challenge Recommendations for a call to action, a statement for healthcare professionals. Circulation. 95:1997;1085-1090
40. Macharia W., Leon G., Rowe B., et al. An overview of intervention to improve compliance with appointment keeping for medical services. JAMA. 267:1992;1813-1817
41. Devine E., Reifschneider E. A meta-analysis of the effects of psychosocial care in adults. Nurs Res. 44:1995;237-245
42. Mullen P., Somons-Morton D., Ramirez G., et al. A meta-analysis of trials evaluating patient education and counseling for three groups of preventive health behaviors. Patient Educ Couns. 32:1997;157-173
43. The Center for Health Studies of Group Health Cooperative of Puget Sound. An indexed bibliography of self-management for people with chronic disease. (ed 1):1996;Center for the Advancement of Health, Washington, DC
44. Haynes R., McKibbon K., Kanani E. Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet. 348:1996;383-386
45. Roth H., Caron H., Hsi B. Estimating a patient's cooperation with his regimen. Am J Med Sci. 262:1971;269-273
46. Gorelick P. Stroke prevention therapy beyond antithrombotics: Unifying mechanisms in ischemic stroke pathogenesis and implications for therapy. An invited review. Stroke. 33:2002;862-875
47. Merrick N., Fink A., Park R., et al. Derivation of clinical indications for carotid endarterectomy by and expert panel. Am J Public Health. 77:1987;187-190
48. Kravitz R., Laouri M., Kahan J., et al. Validity of criteria used for detecting underuse of coronary revascularization. JAMA. 274:1995;632-638
49. Shekelle P., Kahan J., Bernstein S., et al. The reproducibility of a method to identify the overuse of medical procedures. N Engl J Med. 338:1998;1888-1895